Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients with small cell lung cancer (SCLC), both in limited (LD) and diffuse disease (DD).
Clinical implications for pro-GRP in small cell lung cancer. A single center experience / S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 33:1(2018), pp. 55-61. [10.5301/ijbm.5000305]
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
S. Cavalieri;G. Galli;F. Nichetti;F.G.M. DE BRAUD;
2018
Abstract
Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients with small cell lung cancer (SCLC), both in limited (LD) and diffuse disease (DD).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ijbm.5000305.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
490.22 kB
Formato
Adobe PDF
|
490.22 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
